Senior Bloomberg ETF analyst Eric Balchunas spoke about the continuous innovation in ETF industry in 2024, highlighting buffer strategies emerging as a major trend.
What Happened: Speaking on the ETF Prime podcast, Balchunas dubbed these products “boomer drugs” for their ability to eliminate investor worry.
“Buffer ETFs have a Xanax-like quality,” Balchunas said. “What they really do is eliminate your worry, just like a Xanax will probably get you through turbulence on an airplane.”
These ETFs, which use options to provide downside protection while capping upside gains, have grown to $50 billion in assets. Balchunas believes they are “stealing money” from annuities, structured products and even bonds as investors seek alternatives to traditional portfolio hedges.
Another key trend is the rise of leveraged single-stock ETFs, which Balchunas calls “hot sauce” products. The Nvidia 2x leveraged ETF NVDL has already amassed $6 billion in assets.
Also Read: Donald Trump’s Pro-Bitcoin Stance Influenced Ethereum ETF Approval, Analyst Posits
Despite these niche products gaining traction, core index ETFs continue to dominate flows. The Vanguard S&P 500 ETF VOO has taken in $60 billion year-to-date, on pace to potentially double the annual inflow record.
However, the biggest story in the ETF world this year may be the runaway success of spot Bitcoin BTC/USD ETFs. Since their January launch, these products have seen a staggering $18 billion in net inflows over just eight months.
The success of Bitcoin ETFs has silenced many critics and demonstrated the pent-up demand for regulated crypto investment vehicles.
With daily trading volumes regularly exceeding $1 billion, these products have quickly become some of the most actively traded ETFs in the market.
What’s Next: The influence of Bitcoin as an institutional asset class is expected to be thoroughly explored at Benzinga’s upcoming Future of Digital Assets event on Nov. 19.
Read Next:
Image: Shutterstock
This content was partially produced with the help of AI tools and was reviewed and published by Benzinga editors.
Market News and Data brought to you by Benzinga APIs© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
